Literature DB >> 21213215

Chromatin-modifying drugs induce miRNA-153 expression to suppress Irs-2 in glioblastoma cell lines.

Jianzhen Xu1, Xuemei Liao, Na Lu, Wenming Liu, Chi-Wai Wong.   

Abstract

MicroRNAs (miRNAs) are noncoding RNAs that regulate gene expression by inhibiting translation or by promoting mRNA degradation. Previously, we established that microRNA-153 (miR-153) induces apoptosis by downregulating B-cell lymphoma 2 (Bcl-2) and myeloid cell leukemia sequence 1 (Mcl-1) protein expression levels in glioblastoma cell line DBTRG-05MG. In our study, we show that ectopic expression of miR-153 also inhibits the protein kinase B (PKB/Akt) pathway via reducing the protein level of insulin receptor substrate-2 (Irs-2). Moreover, simultaneous treatment with the chromatin-modifying drugs 4-phenylbutyric acid and 5-aza-2'-deoxycytidine induces miR-153 expression to suppress Irs-2, Bcl-2 and Mcl-1 expressions, thus downregulating the survival but upregulating the apoptotic pathways, implying that tumor suppressor miR-153 is a dual life and death regulator.
Copyright © 2011 UICC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21213215     DOI: 10.1002/ijc.25917

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  26 in total

1.  Olea europaea leaf extract alters microRNA expression in human glioblastoma cells.

Authors:  Berrin Tunca; Gulcin Tezcan; Gulsah Cecener; Unal Egeli; Secil Ak; Hulusi Malyer; Gulendam Tumen; Ayhan Bilir
Journal:  J Cancer Res Clin Oncol       Date:  2012-06-22       Impact factor: 4.553

2.  MicroRNA-153 physiologically inhibits expression of amyloid-β precursor protein in cultured human fetal brain cells and is dysregulated in a subset of Alzheimer disease patients.

Authors:  Justin M Long; Balmiki Ray; Debomoy K Lahiri
Journal:  J Biol Chem       Date:  2012-06-25       Impact factor: 5.157

3.  Olea europaea leaf extract improves the treatment response of GBM stem cells by modulating miRNA expression.

Authors:  Gulcin Tezcan; Berrin Tunca; Ahmet Bekar; Ferah Budak; Saliha Sahin; Gulsah Cecener; Unal Egeli; Mevlut Ozgur Taskapılıoglu; Hasan Kocaeli; Sahsine Tolunay; Hulusi Malyer; Cevdet Demir; Gulendam Tumen
Journal:  Am J Cancer Res       Date:  2014-09-06       Impact factor: 6.166

Review 4.  Liquid biopsy in central nervous system tumors: the potential roles of circulating miRNA and exosomes.

Authors:  Yirizhati Aili; Nuersimanguli Maimaitiming; Yusufu Mahemuti; Hu Qin; Yongxin Wang; Zengliang Wang
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

5.  Co-regulation of intragenic microRNA miR-153 and its host gene Ia-2 β: identification of miR-153 target genes with functions related to IA-2β in pancreas and brain.

Authors:  W Mandemakers; L Abuhatzira; H Xu; L A Caromile; S S Hébert; A Snellinx; V A Morais; S Matta; T Cai; A L Notkins; B De Strooper
Journal:  Diabetologia       Date:  2013-04-18       Impact factor: 10.122

6.  The transcribed-ultraconserved regions in prostate and gastric cancer: DNA hypermethylation and microRNA-associated regulation.

Authors:  K Goto; S Ishikawa; R Honma; K Tanimoto; N Sakamoto; K Sentani; N Oue; J Teishima; A Matsubara; W Yasui
Journal:  Oncogene       Date:  2015-12-07       Impact factor: 9.867

Review 7.  Modulation of chemoresponsiveness to platinum-based agents by microRNAs in cancer.

Authors:  Xin Yu; Heyi Zheng; Matthew Tv Chan; William Kk Wu
Journal:  Am J Cancer Res       Date:  2017-09-01       Impact factor: 6.166

Review 8.  Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma.

Authors:  Wanli Yu; Sai Liang; Chunzhi Zhang
Journal:  Neuromolecular Med       Date:  2018-09-04       Impact factor: 3.843

9.  Epigenetic modulation of FBW7/Mcl-1 pathway for lung cancer therapy.

Authors:  Mi Jeong Kim; Guo Chen; Gabriel L Sica; Xingming Deng
Journal:  Cancer Biol Ther       Date:  2020-12-18       Impact factor: 4.742

10.  MicroRNA-based promotion of human neuronal differentiation and subtype specification.

Authors:  Laura Stappert; Lodovica Borghese; Beate Roese-Koerner; Sandra Weinhold; Philipp Koch; Stefanie Terstegge; Markus Uhrberg; Peter Wernet; Oliver Brüstle
Journal:  PLoS One       Date:  2013-03-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.